Carazolol Competitive Antibody Pair

AccuSift
CZL
SKU Name Unit Price Delivery QTY
SR550 Carazolol monoclonal antibody 1mg $750 10days
TC550 Carazolol BSA antigen 1mg $300 10days
AccuSift provides high-performance carazolol competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Carazolol is a non-selective β‑adrenergic receptor blocker that acts by blocking both β1 and β2 receptors. It lacks intrinsic sympathomimetic activity and is more potent than propranolol. In human medicine, it is used to treat hypertension, while in veterinary practice it is primarily employed to reduce stress during animal transport and lower the risk of sudden death. The European Union has established maximum residue limits for carazolol in pork kidneys (25 μg/kg) and muscle (5 μg/kg).
Performance Characteristics:

  • Sensitivity: ELISA IC50: 0.25 ppb

  • Cross‑Reactivity: Carvedilol 2 ppb

  • Source: Mouse Monoclonal Antibody

  • Purity: ≥ 90%

  • Recommended Pairing: (Coating) / (Labeling)

  • Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.


Operation

References